Page 65 - Demo

%u4eba%u6587%u793e%u6703%u8207%u91ab%u5b78%u7684%u8de8%u57df%u7814%u7a76%u8207%u885b%u751f%u653f%u7b56%u8f49%u8b6f%u7684%u6311%u6230%u2500%u4ee5%u7cd6%u5c3f%u75c5%u8ad6%u8cea%u8a08%u916c%u653f%u7b56%u70ba%u4f8b65Hsieh HM, Gu SM, Shin SJ, Kao HY, Lin YC, & Chiu HC. (2015a). Cost-effectiveness of a diabetes payfor-performance program in diabetes patients with multiple chronic conditions. PLoS One, 10(7): e0133163.Hsieh HM, Tsai SL, Shin SJ, Mau LW, & Chiu HC. (2015b). Cost-effectiveness of diabetes pay-forperformance incentive designs. Medical Care, 53(2): 106-115.Hsieh HM, Tsai SL, Mau LW, & Chiu HC. (2016a). Effects of changes in diabetes pay-for-performance incentive designs on patient risk selection. Health Services Research, 51(2): 667-686.Hsieh HM, Shin SJ, Tsai SL, & Chiu HC. (2016b). Effectiveness of pay-for-performance incentive designs on diabetes care. Medical Care, 54(12): 1063-1069.Hsieh HM, Lin TH, Lee IC, Huang CJ, Shin SJ, & Chiu HC. (2016c). The association between participation in a pay-for-performance program and macrovascular complications in patients with type 2 diabetes in Taiwan: A nationwide population-based cohort study. Preventive Medicine, 85: 53-59.Hsieh HM, Chiu HC, Lin YT, & Shin SJ. (2017a). A diabetes pay-for-performance program and the competing causes of death among cancer survivors with type 2 diabetes in Taiwan. International Journal for Quality in Health Care, 29(4): 512-520.Hsieh HM, He JS, Shin SJ, Chiu HC, & Lee CT. (2017b). A diabetes pay-for-performance program and risks of cancer incidence and death in patients with type 2 diabetes in Taiwan. Preventing Chronic Disease, 14: E88.Huang YC, Lee MC, Chou YJ, & Huang N. (2016). Disease-specific pay-for-performance programs: do the P4P effects differ between diabetic patients with and without multiple chronic conditions? Medical Care, 54(11): 977-983.Lai CL, & Hou YH. (2013). The association of clinical guideline adherence and pay-for-performance among patients with diabetes. Journal of the Chinese Medical Association, 76(2): 102-107.Lee IT, Hsu CC, Sheu WH, Su SL, Wu YL, & Lin SY. (2019). Pay-for-performance for shared care of diabetes in Taiwan. Journal of the Formosan Medical Association, 118(Suppl 2): S122-S129.Lee TT, Cheng SH, Chen CC, & Lai MS. (2010). A pay-for-performance program for diabetes care in Taiwan: A preliminary assessment. The American Journal of Managed Care, 16(1): 65-69.Mendelson A, Kondo K, Damberg C, Low A, Motuapuaka M, & Freeman M, et al. (2017). The effects of pay-for-performance programs on health, health care use, and processes of care: A systematic review. Annals of Internal Medicine, 166(5): 341-353.Milgate K, & Cheng SB. (2006). Pay-for-performance: the MedPAC perspective. Health Affairs, 25(2): 413-419.Rosenthal MB, & Frank RG. (2006). What is the empirical basis for paying for quality in health care? Medical Care Research and Review(MCRR), 63(2): 135-157.